Anna Protopapas

Anna Protopapas

Chairman at NUVALENT, INC.

Net worth: - $ as of 2025-12-30

61 year
Health Technology
Consumer Services
Process Industries

Profile

Anna Protopapas is Chief Executive Officer & Director at Flare Therapeutics, Inc. since 2026 and Independent Chairman at Nuvalent, Inc. since 2022.
Former roles include President & Chief Executive Officer at Millennium Pharmaceuticals, Inc. from 2013 to 2014, Independent Director at ARIAD Pharmaceuticals, Inc. from 2015 to 2017, Director at Ensemble Therapeutics Corp., Independent Director at Dicerna Pharmaceuticals, Inc. from 2019 to 2021, Director at Mersana Therapeutics, Inc. from 2023 to 2026, Director at Bioverativ, Inc. from 2017 to 2018, Executive VP-Global Business Development at Takeda Pharmaceutical Co., Ltd. from 2010 to 2014, and Head-Global Business Development at Takeda Pharmaceuticals International, Inc. from 2010 to 2014.
Education includes graduate studies at Massachusetts Institute of Technology, undergraduate studies at Princeton University, and an MBA from Stanford Graduate School of Business.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2026-01-05 0 ( -.--% ) - $ 2025-12-30

Anna Protopapas active positions

CompaniesPositionStart
NUVALENT, INC. Chairman 2022-03-29
Chief Executive Officer 2026-06-29

Former positions of Anna Protopapas

CompaniesPositionEnd
MERSANA THERAPEUTICS Chief Executive Officer 2023-09-09
DICERNA PHARMACEUTICALS, INC. Director/Board Member 2021-06-02
BIOVERATIV INC Director/Board Member 2018-03-07
ARIAD PHARMACEUTICALS, INC. Director/Board Member 2017-01-15
Corporate Officer/Principal 2014-09-30
See the detail of Anna Protopapas's experience

Training of Anna Protopapas

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

83

1st degree connections

13

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies13

Health Technology

Health Technology

Process Industries

Health Technology

Health Technology

Health Technology

Finance

Consumer Services

Commercial Services

Consumer Services

Health Technology

Health Technology

Health Technology

  1. Stock Market
  2. Insiders
  3. Anna Protopapas